Back

Clinical impact of systemic inflammation across the spectrum of different high-sensitivity CRP values in patients undergoing percutaneous coronary intervention

31 August 2024 (07:55 - 08:50)
Organised by: Logo
Congress Presentation Part of: Risk stratification in percutaneous coronary intervention (1) Inflammation and Immunity ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Angelo Oliva

Mount Sinai Hospital, New York (United States of America)

8 More presentations in this session

Presentation thumbnail
A new hydration strategy can reduce contrast-induced acute kidney injury after PCI in patients with chronic heart failure and chronic kidney disease: a two-center randomized controlled trial
Professor K. Chen (Tianjin, CN)
Abstract Slides Video
Presentation thumbnail
Prognostic outcome of ACS in HTX patients after PCI
Ms L. Elbinger (Bad Oeynhausen, DE)
Abstract Slides Video
Presentation thumbnail
The use of allopurinol in prophylaxis against contrast-induced nephropathy in patients undergoing percutaneous coronary intervention
Doctor K. Mahmoud (Cairo, EG)
Abstract Slides Video
Presentation thumbnail
Gender differences in coronary artery disease patterns
Doctor D. Munhoz (Aalst, BE)
Abstract Slides Video
Presentation thumbnail
Impact of neutrophil-to-lymphocyte ratio on clinical outcomes in patients with or without chronic kidney disease undergoing percutaneous coronary intervention
Doctor A. Oliva (New York, US)
Abstract Slides Video

Access the full session

Session thumbnail
Risk stratification in percutaneous coronary intervention (1)

The Event

Event poster

ESC Congress 2024

31 August 2024 07:55 CET
You may be interested in
thumbnail
Congress Presentation
Hs-CRP is a strong predictor of adverse cardiovascular events in patients with chest pain
thumbnail
Congress Presentation
C-reactive protein and cardiovascular risk in the general population
thumbnail
Congress Presentation
High-sensitive CRP is a reliable biomarker for predicting events in a cardiovascular population

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources